CARE Ratings Ltd (BOM:534804)
₹ 990.8 -29.6 (-2.9%) Market Cap: 29.66 Bil Enterprise Value: 23.60 Bil PE Ratio: 29.02 PB Ratio: 4.18 GF Score: 76/100

Q4 2024 CARE Ratings Ltd Earnings Call Transcript

May 10, 2024 / 10:00AM GMT
Release Date Price: ₹1091.05 (-0.91%)

Key Points

Positve
  • CARE Ratings Ltd (BOM:534804) reported a 14% growth in revenue from operations for FY24, reaching INR 283 crore.
  • The company's operating profit for FY24 stood at INR 128 crore, reflecting a 10% increase over FY23.
  • The Board of Directors recommended a final dividend of INR 11 per share, bringing the total dividend for the year to INR 18 per share.
  • The consolidated business performance for FY24 showed a 19% growth in revenue from operations, reaching INR 332 crore.
  • The company has received approval from SEBI to operate as an ESG rating provider, expanding its service offerings.
Negative
  • The private sector CapEx remains sluggish, impacting overall investment growth.
  • There was a slight moderation in the domestic ratings revenue growth in Q4 FY24.
  • The non-rating businesses, particularly the analytics division, are still operating at a loss despite showing promising growth.
  • Increased expenses in the non-rating segment led to a higher EBITDA loss in Q4 FY24.
  • The company faces challenges from volatile commodity prices and geopolitical uncertainties, which could impact future performance.
Operator

Ladies and gentlemen, good day, and welcome to CARE Ratings Limited Q4 and FY24 earnings conference call.

This conference call may contain forward-looking statements about the company, which are based on the believe, and opinions, and expectations company as on date of this call. These statements are not guarantees of future performance and involve risk and uncertainty that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Mehul Pandya, Managing Director and Group CEO. Thank you, and over to you, sir.

Mehul Pandya
CARE Ratings Ltd - Group CEO & MD

Good afternoon, everyone. I hope all of you are doing well. I extend a warm welcome on behalf of the entire CareEdge family to the Q4 and FY24 investor call. First and foremost, I'd like to thank all the investors for having the faith in us and have supported all throughout.

Many of you have been kind enough in terms of suggesting to us new areas to focus upon and I deeply value that. I trust

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot